Batten Disease Treatment Market by Disease Type (Infantile, Late Infantile, Juvenile and Adult) and by Therapy Type includes Occupational Therapy and Physical Therapy: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

March 2018 | 110 pages | ID: B66712A7D14EN
Zion Market Research

Abstracts

The report covers forecast and analysis for the batten disease treatment market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million) the study includes drivers and restraints for the batten disease treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the batten disease treatment market on a global level.

In order to give the users of this report a comprehensive view on the batten disease treatment market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis. Wherein test type segments and therapy segments are benchmarked based on their market size, growth, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the players in the market. In addition, the report also covers key strategic developments of the market including acquisitions and mergers, new technology launch, agreements, partnerships collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, disease portfolio of various companies according to the region.

The study provides a decisive view on the batten disease treatment market by segmenting the market based on disease type and therapy type and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2023. Based on disease market is segmented into Infantile NCL, Late Infantile NCL, Juvenile NCL, and Adult NCL. Therapy type covered in this report includes occupational and physical therapies. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East Africa with its further bifurcation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for Batten disease treatment market based on disease type and therapies in all the regions and countries.

The reports also include detailed profiles of end players such as ReGenX Biosciences LLC, BioMarin Pharmaceuticals, and SenebBioSciences Inc.

This report segments the global batten disease treatment market as follows:

Global Batten Disease Treatment Market: Disease Type Segment Analysis

• Infantile NCL
• Late Infantile NCL
• Juvenile NCL
• Adult NCL

Global Batten Disease Treatment Market: Therapy type Segment Analysis

Occupational Therapy

Physical Therapy

Global Batten Disease Treatment Market: Regional Segment Analysis

• North America
• The U.S.
• Europe
• UK
• France
• Germany
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Middle East and Africa

Contents

CHAPTER 1. INTRODUCTION

1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
  1.3.1. Market research process
  1.3.2. Market research methodology

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Global Batten Disease Treatment market, 2017 - 2023 (USD Million)
2.2. Global Batten Disease Treatment market: Snapshot

CHAPTER 3. BATTEN DISEASE TREATMENT - MARKET DYNAMICS

3.1. Introduction
3.2. Market drivers
  3.2.1. Global Batten Disease Treatment market drivers: Impact analysis
  3.2.2. Increase in the prevalence of Batten disease
  3.2.3. Increase in research and development
3.3. Market Restraints
  3.3.1. Global Batten Disease Treatment market restraints: Impact analysis
  3.3.2. Lack of awareness
3.4. Opportunities
  3.4.1. Drug Discovery and Drug launch
3.5. Porters five forces analysis
  3.5.1. Bargaining power of suppliers
  3.5.2. Bargaining power of buyers
  3.5.3. The threat of new entrants
  3.5.4. The threat of new substitutes
  3.5.5. Degree of competition
3.6. Market attractiveness analysis
  3.6.1. Market attractiveness analysis, by disease type segment
  3.6.2. Market attractiveness analysis, by therapy segment
  3.6.3. Market attractiveness analysis, by regional segment

CHAPTER 4. GLOBAL BATTEN DISEASE TREATMENT MARKET - COMPETITIVE LANDSCAPE

4.1. Company Market Share Analysis
  4.1.1. Global Batten Disease Treatment market: company market share, 2017
4.2. Strategic Development
  4.2.1. Acquisitions Mergers
  4.2.2. New Launch
  4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
  4.2.4. Research Development, and Regional Expansion
4.3. Price Trend Analysis
4.4. Technology Portfolio

CHAPTER 5. GLOBAL BATTEN DISEASE TREATMENT MARKET -DISEASE TYPE SEGMENT ANALYSIS

5.1. Global Batten Disease Treatment market: Disease Type overview
  5.1.1. Global Batten Disease Treatment market revenue share, by disease Type, 2017 and 2023
5.2. Infantile NCL

CHAPTER 6. GLOBAL INFANTILE NCL TREATMENT MARKET, 2017 - 2023(USD MILLION)

6.1. Late Infantile NCL
  6.1.1. Global late infantile NCL Disease Treatment market, 2017 - 2023(USD Million)
6.2. Juvenile NCL
  6.2.1. Global juvenile NCL Treatment market, 2017 - 2023(USD Million)
6.3. Adult NCL
  6.3.1. Global adult NCL Treatment market , 2017 - 2023(USD Million)

CHAPTER 7. GLOBAL BATTEN DISEASE TREATMENT MARKET - THERAPY SEGMENT ANALYSIS

7.1. Global Batten Disease Treatment market: Therapyoverview
  7.1.1. Global Batten Disease Treatment market revenue share, by Therapy, 2017 and 2023
7.2. Occupational therapy
  7.2.1. Global Batten Disease Treatment market by occupational therapy, 2017 - 2023 (USD Million)
7.3. Physical Therapy
  7.3.1. Global Batten Disease Treatment market for physical therapy,2017 - 2023(USD Million)

CHAPTER 8. GLOBAL BATTEN DISEASE TREATMENT MARKET - REGIONAL SEGMENT ANALYSIS

8.1. Global Batten Disease Treatment market: Regional overview
  8.1.1. Global Batten Disease Treatment market revenue share, by region, 2017 and 2023
8.2. North America
  8.2.1. North America Batten Disease Treatment market revenue, by Disease type, 2014 - 2023 (USD Million)
  8.2.2. North America Batten Disease Treatment market revenue, by Therapy, 2014 - 2023 (USD Million)
  8.2.3. U.S.
    8.2.3.1. U.S. Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.2.3.2. U.S. Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.2.4. Canada
    8.2.4.1. Canada Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.2.4.2. Canada Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.2.5. Rest of North America
    8.2.5.1. Rest of North America Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.2.5.2. Rest of North America Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
8.3. Europe
  8.3.1. Europe Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
  8.3.2. Europe Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.3.3. Germany
    8.3.3.1. Germany Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.3.3.2. Germany Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.3.4. France
    8.3.4.1. France Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.3.4.2. France Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.3.5. UK
    8.3.5.1. UK Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.3.5.2. UK Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.3.6. Italy
    8.3.6.1. Italy Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.3.6.2. Italy Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.3.7. Spain
    8.3.7.1. Spain Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.3.7.2. Spain Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.3.8. Russia
    8.3.8.1. Russia Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.3.8.2. Russia Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.3.9. Rest of Europe
    8.3.9.1. Rest of Europe Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.3.9.2. Rest of Europe Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
8.4. Asia Pacific
  8.4.1. Asia Pacific Batten Disease Treatment market revenue, by disease type, 2014 - 2023, (USD Million)
  8.4.2. Asia Pacific Batten Disease Treatment market revenue, by therapy, 2014 - 2023, (USD Million)
  8.4.3. China
    8.4.3.1. China Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.4.3.2. China Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.4.4. Japan
    8.4.4.1. Japan Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.4.4.2. Japan Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.4.5. India
    8.4.5.1. India Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.4.5.2. India Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.4.6. Australia
    8.4.6.1. Australia Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.4.6.2. Australia Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.4.7. Rest of Asia Pacific
    8.4.7.1. Rest of Asia Pacific Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.4.7.2. Rest of Asia Pacific Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
8.5. Latin America
  8.5.1. Latin America Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
  8.5.2. Latin America Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
  8.5.3. Mexico
    8.5.3.1. Mexico Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.5.3.2. Mexico Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.5.4. Brazil
    8.5.4.1. Brazil Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.5.4.2. Brazil Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.5.5. Argentina
    8.5.5.1. Argentina Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.5.5.2. Argentina Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.5.6. Rest of Latin America
    8.5.6.1. Rest of Latin America Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.5.6.2. Rest of Latin America Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
8.6. Middle East and Africa
  8.6.1. Middle East and Africa Batten Disease Treatment market revenue, by disease type, 2014 - 2023 (USD Million)
  8.6.2. Middle East and Africa Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.6.3. Saudi Arabia
    8.6.3.1. Saudi Arabia Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.6.3.2. Saudi Arabia Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.6.4. UAE
    8.6.4.1. UAE Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.6.4.2. UAE Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.6.5. South Africa
    8.6.5.1. South Africa Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.6.5.2. South Africa Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.6.6. Qatar
    8.6.6.1. Qatar Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.6.6.2. Qatar Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  8.6.7. Rest of Middle East Africa
    8.6.7.1. Rest of Middle East Africa Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
    8.6.7.2. Rest of Middle East Africa Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)

CHAPTER 9. COMPANY PROFILE

9.1. ReGenX Biosciences LLC
  9.1.1. Overview
  9.1.2. Financials
  9.1.3. Disease type portfolio
  9.1.4. Business strategy
  9.1.5. Recent developments
9.2. BioMarin Pharmaceuticals
  9.2.1. Overview
  9.2.2. Financials
  9.2.3. Disease type portfolio
  9.2.4. Business strategy
  9.2.5. Recent developments
9.3. SenebBioSciences Inc.
  9.3.1. Overview
  9.3.2. Financials
  9.3.3. Disease type portfolio
  9.3.4. Business strategy
  9.3.5. Recent developments